Some stumbles will make this a challenging year for the specialty pharmacy.
News & Analysis: Diplomat Pharmacy
DPLO earnings call for the period ending December 31, 2018.
2019 will be a rebuilding year for the specialty pharmacy.
A good day for the market couldn't save these stocks from big losses. Find out why.
Managing pharmacy benefits has been a lot harder than the specialty pharmacy expected.
The company's PBM business isn't paying off yet.
The specialty pharmacy is still getting its feet wet as a pharmacy benefits manager.
The specialty pharmacy is having trouble justifying its pharmacy benefit manager purchases.
DPLO earnings call for the period ending September 30, 2018.
Higher expenses turn solid revenue growth into a second-quarter loss for the pharmacy benefit manager and specialty pharmacy combination.